What the fuss is all about? – L’Equipe
The biggest story in sports medicine this week is the announcement that Dr. David DeFilippo has been placed on leave.
The news was first reported by the Associated Press.
Dr. DeFilipe, who has been a professor at Boston Children’s Hospital since 2011, had been on leave since early June.
His leave was extended last week in light of a “family health and safety issue,” according to a hospital release.
In a statement on Thursday, Boston Childrens Hospital said that while Dr. De Filippo was in a good health and that he was performing well, he was unable to return to Boston Children for “medical and surgical reasons.”
The hospital also said that it had no plans to hire him.
“The safety and well-being of our patients and staff is of paramount importance to the Boston Children Hospital, and we are committed to supporting our doctors and staff while this matter is resolved,” the hospital said.
Boston Childrens said it had suspended the practice of treating children with corneal polyps in order to ensure proper oversight of its care.
“We want to assure our patients, our community and the community at large that we will be transparent with them about what has happened,” the statement said.
Dr DeFilia was previously a member of the prestigious Stanford Children’s Medical Center, where he led a group that developed an effective way to treat patients with the most common form of corneitis, a rare, life-threatening condition.
The university has had a track record of successful treatments for corneas that were originally discovered in the 1970s.
Since 2000, the hospital has treated 1,073 children with congenital and hereditary corneomas.
Earlier this year, Boston Health Care System announced it was suspending all routine operations and procedures at its Children’s Health Care facility, including the routine screening of children for the condition.